Latest Articles

AI is already reshaping the clinical trials industry and that transformation looks set to continue over the next five years. New technologies will enable the development of more personalized medicines, empower more responsive trial designs and improve informed decision making by unlocking new data insights. read more

With the increasing complexities of current IND programs, it is critical to work with regulatory agencies to seek input early in the process. read more